TXNRD1 and hepatocellular carcinoma: Studies by Lee et al. (2019) showed that thioredoxin reductase 1 (TXNRD1) is significantly overexpressed in cytoplasmic subunits and is a key enzyme of the thioredoxin system, and is related to poor clinical pathological features and survival outcomes of HCC patients.